Li et al., demonstrated that miRNA-128 inhibits prostate cancer through BMI-1 (Jin et al., 2014), and Yu et al., showed that miR-200b regulates BMI-1 to curtail growth and migration of cancer cells, and to enhance their chemosensitivity (Yu et al., 2014). This evidence concerns the gene BMI1 and Familial prostate cancer.